Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Shirley DT, Farr L, Watanabe K, Moonah S. A review of the global burden, new diagnostics, and current therapeutics for amebiasis. Open Forum Infect Dis. 2018;5(7):ofy161. https://doi.org/10.1093/ofid/ofy161
2. Van Den Broucke S, Verschueren J, Van Esbroeck M, Bottieau E, Van den Ende J. Clinical and microscopic predictors of Entamoeba histolytica intestinal infection in travelers and migrants diagnosed with Entamoeba histolytica/dispar infection. PLoS Negl Trop Dis. 2018;12(10):e0006892.
3. Beg MY, Bains L, Mahajan R, Lal P, Choudhury S, Kumar NP, Momin EW, Pal V. Fulminant necrotising amoebic colitis of whole of large bowel: a rare complication of a common infectious disease. Case Rep Infect Dis. 2020;11:2020.
4. Kantor M, Abrantes A, Estevez A, Schiller A, Torrent J, Gascon J, Hernandez R, Ochner C. Entamoeba histolytica: updates in clinical manifestation, pathogenesis, and vaccine development. Can J Gastroenterol Hepatol. 2018;2:2018.
5. Wee LE, Ding CSL, Suresh KN, Lim PL. A bedbound 71-year-old Singaporean male nursing home resident with an ulcerating perianal mass. Clin Infect Dis. 2021;72(4):718–9. https://doi.org/10.1093/cid/ciaa916.